Stephanie Crowley McWilliam
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 35 | 2024 | 283 | 7.870 |
Why?
|
| Sleep | 31 | 2024 | 272 | 6.960 |
Why?
|
| Melatonin | 21 | 2023 | 96 | 4.810 |
Why?
|
| Light | 13 | 2023 | 74 | 2.890 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 12 | 2021 | 39 | 2.290 |
Why?
|
| Adolescent | 26 | 2024 | 1998 | 1.670 |
Why?
|
| Work Schedule Tolerance | 4 | 2018 | 38 | 1.490 |
Why?
|
| Biological Clocks | 4 | 2018 | 16 | 1.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2020 | 167 | 1.400 |
Why?
|
| Schools | 5 | 2022 | 47 | 1.350 |
Why?
|
| Wakefulness | 5 | 2017 | 77 | 1.350 |
Why?
|
| Circadian Clocks | 4 | 2020 | 35 | 1.290 |
Why?
|
| Blood Glucose | 5 | 2017 | 95 | 1.280 |
Why?
|
| Seasons | 6 | 2021 | 28 | 1.150 |
Why?
|
| Female | 40 | 2024 | 13874 | 1.100 |
Why?
|
| Humans | 57 | 2024 | 25227 | 1.020 |
Why?
|
| Adolescent Development | 2 | 2018 | 5 | 1.010 |
Why?
|
| Male | 36 | 2024 | 13573 | 0.960 |
Why?
|
| Saliva | 9 | 2015 | 49 | 0.920 |
Why?
|
| Puberty | 2 | 2015 | 10 | 0.900 |
Why?
|
| Adolescent Behavior | 2 | 2018 | 30 | 0.870 |
Why?
|
| Adult | 25 | 2022 | 7089 | 0.860 |
Why?
|
| Interleukin-2 | 2 | 2020 | 24 | 0.850 |
Why?
|
| Time Factors | 14 | 2020 | 1329 | 0.830 |
Why?
|
| Homeostasis | 4 | 2018 | 52 | 0.820 |
Why?
|
| Sex Characteristics | 3 | 2017 | 121 | 0.750 |
Why?
|
| Sleep Wake Disorders | 5 | 2024 | 109 | 0.720 |
Why?
|
| Melanoma | 2 | 2020 | 50 | 0.700 |
Why?
|
| Single-Domain Antibodies | 1 | 2020 | 1 | 0.700 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 7 | 0.690 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 83 | 0.670 |
Why?
|
| Photoperiod | 4 | 2017 | 47 | 0.670 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2019 | 1 | 0.670 |
Why?
|
| Peyer's Patches | 1 | 2019 | 2 | 0.670 |
Why?
|
| Natural Killer T-Cells | 1 | 2019 | 4 | 0.670 |
Why?
|
| Peptides | 1 | 2020 | 93 | 0.650 |
Why?
|
| Child | 14 | 2024 | 1232 | 0.640 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 125 | 0.620 |
Why?
|
| Students | 3 | 2019 | 39 | 0.590 |
Why?
|
| Entorhinal Cortex | 1 | 2017 | 32 | 0.590 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 70 | 0.570 |
Why?
|
| Young Adult | 8 | 2021 | 1751 | 0.570 |
Why?
|
| Neuroimaging | 1 | 2017 | 133 | 0.550 |
Why?
|
| Feeding Behavior | 2 | 2014 | 76 | 0.540 |
Why?
|
| Depression | 4 | 2017 | 397 | 0.530 |
Why?
|
| Models, Neurological | 1 | 2015 | 22 | 0.520 |
Why?
|
| Specimen Handling | 1 | 2015 | 40 | 0.510 |
Why?
|
| Surveys and Questionnaires | 11 | 2021 | 1038 | 0.500 |
Why?
|
| Jet Lag Syndrome | 5 | 2022 | 16 | 0.500 |
Why?
|
| Middle Aged | 13 | 2021 | 8144 | 0.480 |
Why?
|
| Occupational Health | 1 | 2014 | 16 | 0.480 |
Why?
|
| Feeding and Eating Disorders | 1 | 2014 | 10 | 0.460 |
Why?
|
| Affect | 1 | 2014 | 58 | 0.450 |
Why?
|
| Actigraphy | 4 | 2014 | 85 | 0.440 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 1113 | 0.440 |
Why?
|
| Sleep Stages | 1 | 2012 | 27 | 0.420 |
Why?
|
| Mice | 6 | 2023 | 1198 | 0.390 |
Why?
|
| Child Development | 1 | 2011 | 67 | 0.360 |
Why?
|
| Parkinson Disease | 1 | 2017 | 818 | 0.330 |
Why?
|
| Aging | 2 | 2015 | 1534 | 0.330 |
Why?
|
| Body Mass Index | 5 | 2021 | 395 | 0.320 |
Why?
|
| Body Weight | 2 | 2019 | 117 | 0.320 |
Why?
|
| Pediatric Obesity | 2 | 2019 | 45 | 0.310 |
Why?
|
| Animals | 6 | 2023 | 3382 | 0.300 |
Why?
|
| Child, Preschool | 4 | 2024 | 588 | 0.300 |
Why?
|
| Dental Caries | 4 | 2000 | 5 | 0.300 |
Why?
|
| Neoplasms | 2 | 2021 | 213 | 0.280 |
Why?
|
| Aged | 8 | 2020 | 8432 | 0.260 |
Why?
|
| NF-kappa B | 2 | 2023 | 91 | 0.250 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 232 | 0.250 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2023 | 3 | 0.250 |
Why?
|
| Darkness | 2 | 2005 | 17 | 0.240 |
Why?
|
| Mood Disorders | 1 | 2004 | 29 | 0.240 |
Why?
|
| Arousal | 1 | 2004 | 41 | 0.240 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 87 | 0.240 |
Why?
|
| Dermatitis, Atopic | 1 | 2024 | 12 | 0.230 |
Why?
|
| Clothing | 1 | 2003 | 3 | 0.230 |
Why?
|
| Phototherapy | 3 | 2013 | 38 | 0.230 |
Why?
|
| Immunotherapy | 2 | 2021 | 51 | 0.220 |
Why?
|
| Preventive Dentistry | 2 | 2000 | 2 | 0.220 |
Why?
|
| Time Management | 1 | 2023 | 5 | 0.210 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 1 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 61 | 0.210 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 59 | 0.210 |
Why?
|
| Universities | 1 | 2022 | 35 | 0.200 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 47 | 0.190 |
Why?
|
| Public Health Dentistry | 2 | 2000 | 2 | 0.190 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 4 | 0.190 |
Why?
|
| Cells, Cultured | 2 | 2020 | 468 | 0.190 |
Why?
|
| Phagocytes | 1 | 2021 | 23 | 0.190 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 18 | 0.190 |
Why?
|
| Bacteria | 1 | 2021 | 70 | 0.190 |
Why?
|
| Meals | 1 | 2021 | 11 | 0.190 |
Why?
|
| Weight Gain | 1 | 2021 | 61 | 0.180 |
Why?
|
| Photic Stimulation | 2 | 2015 | 37 | 0.180 |
Why?
|
| Models, Economic | 1 | 2000 | 7 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2021 | 60 | 0.180 |
Why?
|
| Cognition | 2 | 2019 | 1273 | 0.180 |
Why?
|
| Hepatitis B, Chronic | 1 | 2000 | 3 | 0.180 |
Why?
|
| Lamivudine | 1 | 2000 | 8 | 0.180 |
Why?
|
| Camelids, New World | 1 | 2020 | 1 | 0.180 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 2 | 0.180 |
Why?
|
| Adie Syndrome | 1 | 2020 | 1 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 3 | 0.170 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 6 | 0.170 |
Why?
|
| Drug Synergism | 1 | 2020 | 38 | 0.170 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 5 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 22 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 36 | 0.170 |
Why?
|
| Autoantigens | 1 | 2020 | 20 | 0.170 |
Why?
|
| Body Height | 1 | 2019 | 32 | 0.170 |
Why?
|
| Leukoaraiosis | 1 | 2019 | 7 | 0.170 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 186 | 0.170 |
Why?
|
| Galactosylceramides | 1 | 2019 | 1 | 0.170 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2019 | 1 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 2 | 0.170 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 53 | 0.170 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 4 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2000 | 67 | 0.170 |
Why?
|
| Interleukin-4 | 1 | 2019 | 14 | 0.170 |
Why?
|
| Vaccination | 1 | 2019 | 29 | 0.160 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 3 | 0.160 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Interleukin-15 | 1 | 2019 | 7 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 181 | 0.160 |
Why?
|
| Drug Design | 1 | 2019 | 23 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 101 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2019 | 111 | 0.160 |
Why?
|
| Immunoglobulin Fragments | 1 | 2018 | 1 | 0.150 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2018 | 6 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 3 | 0.150 |
Why?
|
| United States | 3 | 2021 | 1905 | 0.150 |
Why?
|
| Wechsler Memory Scale | 1 | 2017 | 1 | 0.150 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 192 | 0.150 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 6 | 0.140 |
Why?
|
| Software | 1 | 2017 | 65 | 0.140 |
Why?
|
| Human Migration | 1 | 2017 | 2 | 0.140 |
Why?
|
| Africa | 1 | 2017 | 8 | 0.140 |
Why?
|
| Europe | 1 | 2017 | 66 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 642 | 0.130 |
Why?
|
| Sleep-Wake Transition Disorders | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cariostatic Agents | 4 | 2000 | 4 | 0.130 |
Why?
|
| Preoptic Area | 1 | 2015 | 6 | 0.130 |
Why?
|
| Glycemic Index | 1 | 2015 | 2 | 0.130 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2015 | 15 | 0.130 |
Why?
|
| Thailand | 1 | 2015 | 10 | 0.130 |
Why?
|
| Neural Inhibition | 1 | 2015 | 8 | 0.130 |
Why?
|
| Sexual Maturation | 1 | 2015 | 2 | 0.130 |
Why?
|
| Nerve Net | 1 | 2015 | 46 | 0.130 |
Why?
|
| Fluorides | 3 | 2000 | 3 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2022 | 380 | 0.120 |
Why?
|
| Occupations | 1 | 2014 | 14 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 1 | 0.120 |
Why?
|
| Syndrome | 1 | 2014 | 71 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 836 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Breakfast | 1 | 2013 | 1 | 0.110 |
Why?
|
| Eating | 1 | 2014 | 50 | 0.110 |
Why?
|
| Age Factors | 2 | 2017 | 721 | 0.110 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 22 | 0.110 |
Why?
|
| Psychotherapy | 1 | 2013 | 33 | 0.110 |
Why?
|
| Neurons | 1 | 2015 | 288 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2014 | 163 | 0.110 |
Why?
|
| Algorithms | 1 | 2015 | 351 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 4 | 2000 | 119 | 0.100 |
Why?
|
| Prevalence | 1 | 2014 | 421 | 0.100 |
Why?
|
| Pit and Fissure Sealants | 4 | 2000 | 4 | 0.100 |
Why?
|
| Jamaica | 2 | 2021 | 2 | 0.090 |
Why?
|
| Ghana | 2 | 2021 | 4 | 0.090 |
Why?
|
| South Africa | 2 | 2021 | 12 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1307 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2021 | 1758 | 0.090 |
Why?
|
| Energy Intake | 3 | 2017 | 69 | 0.090 |
Why?
|
| Random Allocation | 1 | 2010 | 106 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3105 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1191 | 0.080 |
Why?
|
| DMF Index | 4 | 2000 | 4 | 0.070 |
Why?
|
| Victoria | 4 | 2000 | 6 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 512 | 0.060 |
Why?
|
| Health Status | 1 | 2007 | 210 | 0.060 |
Why?
|
| Aviation | 1 | 2005 | 4 | 0.060 |
Why?
|
| Work | 1 | 2005 | 10 | 0.060 |
Why?
|
| Program Evaluation | 3 | 2000 | 117 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2004 | 8 | 0.060 |
Why?
|
| Body Temperature | 1 | 2004 | 50 | 0.060 |
Why?
|
| Mental Recall | 1 | 2004 | 66 | 0.060 |
Why?
|
| Diet | 2 | 2017 | 164 | 0.060 |
Why?
|
| Mouthwashes | 3 | 1998 | 6 | 0.060 |
Why?
|
| Rest | 1 | 2024 | 30 | 0.060 |
Why?
|
| Lighting | 1 | 2003 | 14 | 0.060 |
Why?
|
| School Dentistry | 2 | 2000 | 2 | 0.060 |
Why?
|
| Immunity | 1 | 2023 | 16 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2004 | 159 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2003 | 3 | 0.050 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2022 | 2 | 0.050 |
Why?
|
| Depression, Postpartum | 1 | 2003 | 13 | 0.050 |
Why?
|
| DNA Damage | 1 | 2022 | 26 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 40 | 0.050 |
Why?
|
| Apoptosis | 1 | 2023 | 187 | 0.050 |
Why?
|
| Inflammation | 1 | 2024 | 255 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 53 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 49 | 0.050 |
Why?
|
| Feces | 1 | 2021 | 109 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2021 | 59 | 0.050 |
Why?
|
| Mothers | 1 | 2003 | 151 | 0.050 |
Why?
|
| Regional Health Planning | 1 | 2000 | 4 | 0.050 |
Why?
|
| Rural Health Services | 1 | 2000 | 3 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 903 | 0.050 |
Why?
|
| Adolescent Health Services | 1 | 2000 | 6 | 0.050 |
Why?
|
| Macrophages | 1 | 2021 | 104 | 0.040 |
Why?
|
| Seychelles | 1 | 2020 | 1 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 2 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2000 | 30 | 0.040 |
Why?
|
| Time | 1 | 2019 | 13 | 0.040 |
Why?
|
| Epidemics | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2020 | 39 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 48 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2019 | 74 | 0.040 |
Why?
|
| Public Health | 1 | 2019 | 62 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 11 | 0.040 |
Why?
|
| Protein Stability | 1 | 2019 | 5 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 8 | 0.040 |
Why?
|
| Self Report | 1 | 2020 | 199 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 64 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 136 | 0.040 |
Why?
|
| Executive Function | 1 | 2019 | 113 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2019 | 72 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 186 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 49 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 118 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 7 | 0.040 |
Why?
|
| Alkenes | 1 | 1998 | 1 | 0.040 |
Why?
|
| Epoxy Compounds | 1 | 1998 | 2 | 0.040 |
Why?
|
| Metalloporphyrins | 1 | 1998 | 3 | 0.040 |
Why?
|
| Incidence | 1 | 2000 | 669 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 939 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 191 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 195 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 2175 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 359 | 0.030 |
Why?
|
| Insulin | 1 | 2013 | 75 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 231 | 0.030 |
Why?
|
| Health Education, Dental | 2 | 1998 | 2 | 0.020 |
Why?
|
| Fluoridation | 2 | 1998 | 2 | 0.020 |
Why?
|
| Oral Hygiene | 2 | 1998 | 5 | 0.020 |
Why?
|
| MMPI | 1 | 2005 | 6 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 27 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 70 | 0.020 |
Why?
|
| Personality | 1 | 2005 | 54 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 4523 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 47 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 302 | 0.010 |
Why?
|
| Dental Caries Susceptibility | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1998 | 1 | 0.010 |
Why?
|
| World Health Organization | 1 | 1998 | 11 | 0.010 |
Why?
|
| Observer Variation | 1 | 1998 | 87 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 124 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 239 | 0.010 |
Why?
|
| Dental Auxiliaries | 1 | 1998 | 1 | 0.010 |
Why?
|
| Dentists | 1 | 1998 | 1 | 0.010 |
Why?
|
| Dental Care for Children | 1 | 1998 | 2 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 3 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1998 | 3 | 0.010 |
Why?
|
| Water Supply | 1 | 1998 | 4 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 9 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1998 | 10 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Copper | 1 | 1998 | 13 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1998 | 11 | 0.010 |
Why?
|
| Dental Health Services | 1 | 1997 | 1 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 34 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 42 | 0.010 |
Why?
|
| Cost Savings | 1 | 1998 | 25 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 1997 | 23 | 0.010 |
Why?
|
| Health Resources | 1 | 1998 | 20 | 0.010 |
Why?
|
| Efficiency, Organizational | 1 | 1997 | 15 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 1997 | 18 | 0.010 |
Why?
|
| Health Policy | 1 | 1998 | 50 | 0.010 |
Why?
|
| Protons | 1 | 1998 | 82 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1997 | 94 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1997 | 122 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1997 | 116 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 1622 | 0.010 |
Why?
|